Skip to main content

Pharma News

 

Clinical courses

 

Clinical courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Loss of Auditory Nerve Fibers Uncovered in Individuals with Tinnitus

    A new study from Mass Eye and Ear investigators shows that individuals who report tinnitus, which present as a ringing in the ears in more than one out of ten adults worldwide, are experiencing auditory nerve loss that is not picked up by conventional hearing tests.

  • A patch of protection against Zika virus

    A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne Zika virus.

    A prototype using The University of Queensland-developed and Vaxxas-commercialised high-density microarray patch (HD-MAP) has delivered a University of Adelaide-developed vaccine and elicited an effective immune response to Zika virus in mice.

  • Recognizing Excellence in Science, Merck honors the Remarkable Merck Young Scientists Awards 2023

    Merck, a leading science and technology company, has announced the winners of Merck Young Scientist Award 2023, season-3 to recognise young scientists in India.

  • AAPP recommends changes in draft rules of National pharmacy commission Bill

    The Association of Advanced pharmacy practitioners (AAPP) strongly urges the government of India to change certain drafted rules of National pharmacy commission Bill. The recommendations of AAPP mainly focused on number of members in council, minimum qualification to registered as pharmacist and national level entrance examination to enter in pharmacy education.

  • PCI launched DIGI-PHARMed application for pharmacists

    The Pharmacy Council of India (PCI) will launch a revamped – DIGI-PHARMed application on December 1 with four integrated services having an objective to regulate the Pharmacy education in the country by enrollment/ registration of Pharmacy institutions/ Pharmacist/ Pharmacy student/ Pharmacist jobseeker across India.

  • Zydus receives final approval from the USFDA for Ivabradine Tablets, 5 mg and 7.5 mg

    Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Ivabradine Tablets, 5 mg and 7.5 mg (USRLD: Corlanor® Tablets, 5 mg and 7.5 mg).

  • Nano-sized cell particles are promising intervention tool in treating infectious diseases

    The COVID-19 pandemic demonstrated the importance of being prepared with drug interventions to contain viral outbreaks that can otherwise have devastating consequences. In preparing for the next pandemic—or Disease X, there is an urgent need for versatile platform technologies that could be repurposed upon short notice, to combat infectious outbreaks.

  • Novel study finds aspirin-free regimen benefits patients with LVAD

    The ARIES-HM3 Randomized Clinical Trial assessed the safety and efficacy of excluding aspirin from the antithrombotic regimen in patients with advanced heart failure who have undergone implantation of a fully magnetically levitated left ventricular assist device (LVAD).

  • Researchers Develop a New Model by Leveraging an Old Vaccine to Build Better Tuberculosis Vaccines

    Despite TB’s wide reach and some lost progress during the COVID-19 pandemic, researchers believe it is possible to eradicate TB through advances in vaccine development and public health. To cross the finish line, scientists must find ways to test new vaccines rapidly to prevent TB infections more effectively. 

  • Researchers Identify Cell Signaling Pathway Controlling Melanoma Cell Metastasis to the Brain

    Melanoma is the deadliest form of skin cancer because of its ability to quickly grow and spread throughout the body. More than half of those with advanced melanoma will see the disease spread to the brain, where it rapidly progresses, often leading to death in only three to four months. Researchers in Moffitt Cancer Center’s Donald A. Adam Melanoma and Skin Cancer Center of Excellence have been working to better understand what drives melanoma brain metastasis.

Subscribe to Pharma News